医薬品有効成分/APIの世界市場予測(~2021):種類別(新薬、ジェネリック)、メーカー別、合成別、製品別、薬品別、治療別...市場調査レポートについてご紹介

【英文タイトル】Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 28)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 32)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Industry Insights
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 41)

4 Premium Insights (Page No. – 47)
4.1 Active Pharmaceutical Ingredients Market Overview
4.2 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
4.3 Active Pharmaceutical Ingredients Market, By Therapeutic Area
4.4 Biotech Active Pharmaceutical Ingredients Market, By Product
4.5 Active Pharmaceutical Ingredients Market, By Type of Drug
4.6 Active Pharmaceutical Ingredients Market: Geographic Snapshot

5 Market Overview (Page No. – 52)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic Diseases
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Technological Advancements in Api Manufacturing
5.2.1.4 Growing Importance of Generics
5.2.1.5 Rapidly Increasing Geriatric Population
5.2.1.6 Increase in Abbreviated New Drug Applications (ANDA)
5.2.1.7 Increasing Uptake of Biopharmaceuticals
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements
5.2.2.2 Unfavorable Drug Price Control Policies Across Various Countries
5.2.3 Opportunities
5.2.3.1 Emerging Biosimilars Market
5.2.3.2 Increasing Scope for High-Potency Active Pharmaceutical Ingredients
5.2.3.3 Emerging Markets
5.2.3.4 Emerging Technologies
5.2.4 Challenges
5.2.4.1 Product Differentiation
5.2.4.2 High Manufacturing Costs

6 Active Pharmaceutical Ingredients Market, By Type (Page No. – 64)
6.1 Introduction
6.2 Innovative Active Pharmaceutical Ingredients
6.3 Generic Active Pharmaceutical Ingredients

7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer (Page No. – 73)
7.1 Introduction
7.2 Captive Manufacturers
7.3 Merchant Api Manufacturers
7.3.1 Merchant Manufacturers Market, By Type
7.3.1.1 Innovative Merchant Api Manufacturers
7.3.1.2 Generic Merchant Api Manufacturers
7.3.2 Merchant Api Manufacturers Market, By Mode of Synthesis
7.3.2.1 Synthetic APIS
7.3.2.2 Biotech APIS

8 Active Pharmaceutical Ingredients Market, By Type of Synthesis (Page No. – 92)
8.1 Introduction
8.2 Synthetic Active Pharmaceutical Ingredients
8.2.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
8.2.1.1 Innovative Synthetic APIS
8.2.1.2 Generic Synthetic APIS
8.3 Biotech Active Pharmaceutical Ingredients
8.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
8.3.1.1 Innovative Biotech APIS
8.3.1.2 Biosimilars
8.3.2 Biotech Active Pharmaceutical Ingredients Market, By Product
8.3.2.1 Monoclonal Antibodies
8.3.2.2 Vaccines
8.3.2.3 Hormones and Growth Factors
8.3.2.4 Cytokines
8.3.2.5 Fusion Proteins
8.3.2.6 Therapeutic Enzymes
8.3.2.7 Blood Factors
8.3.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
8.3.3.1 Mammalian Expression Systems
8.3.3.2 Microbial Expression Systems
8.3.3.3 Yeast Expression Systems
8.3.3.4 Plant Expression Systems
8.3.3.5 Insect Expression Systems

9 Active Pharmaceutical Ingredients Market, By Type of Drug (Page No. – 138)
9.1 Introduction
9.2 Prescription Drugs
9.3 Over-The-Counter Drugs
9.4 Active Pharmaceutical Ingredients Market, By Potency
9.4.1 Low to Moderate Potency Active Pharmaceutical Ingredients
9.4.2 Potent to Highly Potent Active Pharmaceutical Ingredients

10 Active Pharmaceutical Ingredients Market, By Therapeutic Application (Page No. – 149)
10.1 Introduction
10.2 Oncology
10.3 Cardiovascular Disease
10.4 Diabetes
10.5 Central Nervous System and Neurological Disorders
10.6 Endocrinology
10.7 Other Therapeutic Applications

11 Active Pharmaceutical Ingredients Market, By Region (Page No. – 167)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of Asia (RoA)
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 263)
12.1 Overview
12.2 Market Player Ranking
12.3 Competitive Situation and Trends
12.3.1 Agreements, Collaborations, Partnerships, Joint Ventures, and Alliances
12.3.2 Regulatory Approvals
12.3.3 Mergers and Acquisitions
12.3.4 Expansions
12.3.5 Investments

13 Company Profiles (Page No. – 271)
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
13.1 Introduction
13.2 Pfizer, Inc.
13.3 Novartis International AG
13.4 Sanofi
13.5 Boehringer Ingelheim
13.6 Bristol-Myers Squibb
13.7 Teva Pharmaceutical Industries Ltd.
13.8 ELI Lilly and Company
13.9 Glaxosmithkline PLC
13.10 Merck & Co., Inc.
13.11 Abbvie Inc.

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 297)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details


【レポート販売概要】

■ タイトル:医薬品有効成分/APIの世界市場予測(~2021):種類別(新薬、ジェネリック)、メーカー別、合成別、製品別、薬品別、治療別
■ 英文:Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021
■ 発行日:2017年1月10日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-PH-1262
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。